Gene G. Kinney Insider Trading $PRTA PROTHENA CORP PUBLIC LTD CO

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Gene G. Kinney.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Gene G. Kinney. Gene G. Kinney is CSO & Head of R&D in Prothena Corp plc ($PRTA) and President and CEO in Prothena Corp plc ($PRTA) and See Remarks in Prothena Corp plc ($PRTA).

Gene G. Kinney in PROTHENA CORP PUBLIC LTD CO

Trading Symbol: PRTA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gene G. Kinney: President and CEO, See Remarks, CSO & Head of R&D
Holdings: 12,793 shares
Current Value: $633,254
Latest Transaction: Aug 19 2020
$PRTA Market Capitalization: $1.71B
$PRTA Previous Close: $49.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Gene G. Kinney in PROTHENA CORP PUBLIC LTD CO

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Aug 19 2020PRTAPROTHENA CORP PUBL ...Kinney Gene G.President and CEOOption ExerciseM6.4110,00064,10099,074
Aug 19 2020PRTAPROTHENA CORP PUBL ...Kinney Gene G.President and CEOBuyM6.4110,00064,10012,7932.8 K to 12.8 K (+358.04 %)
Feb 27 2020PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseA12.15200,0002,430,000200,000
Mar 01 2019PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseA13.53245,0003,314,850245,000
Jun 25 2018PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseA15.04620,0009,324,800620,000
Feb 23 2018PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseA33.10187,0006,189,700187,000
Sep 29 2017PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.412,80017,948109,074
Sep 29 2017PRTAProthena Corp plcKinney Gene G.President and CEOSellS70.002,800196,0002,7935.6 K to 2.8 K (-50.06 %)
Sep 29 2017PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.412,80017,9485,5932.8 K to 5.6 K (+100.25 %)
Mar 03 2017PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.4125,163161,295111,874
Mar 03 2017PRTAProthena Corp plcKinney Gene G.President and CEOSellS61.2412,822785,2762,79315.6 K to 2.8 K (-82.11 %)
Mar 03 2017PRTAProthena Corp plcKinney Gene G.President and CEOSellS60.2812,341743,97215,61528 K to 15.6 K (-44.14 %)
Mar 03 2017PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.4125,163161,29527,9562.8 K to 28 K (+900.93 %)
Mar 02 2017PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.413,79624,332137,037
Mar 02 2017PRTAProthena Corp plcKinney Gene G.President and CEOSellS60.003,796227,7602,7936.6 K to 2.8 K (-57.61 %)
Mar 02 2017PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.413,79624,3326,5892.8 K to 6.6 K (+135.91 %)
Nov 10 2016PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.418,54854,793140,833
Nov 10 2016PRTAProthena Corp plcKinney Gene G.President and CEOSellS55.328,548472,9052,79311.3 K to 2.8 K (-75.37 %)
Nov 10 2016PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.418,54854,79311,3412.8 K to 11.3 K (+306.05 %)
Nov 04 2016PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseA45.1330,0001,353,90030,000
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.415,83437,396149,381
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOOption ExerciseM6.4114,78594,772155,215
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOSellS55.155,834321,7452,7938.6 K to 2.8 K (-67.62 %)
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.415,83437,3968,6272.8 K to 8.6 K (+208.88 %)
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOSellS55.0814,785814,3582,79317.6 K to 2.8 K (-84.11 %)
Oct 21 2016PRTAProthena Corp plcKinney Gene G.President and CEOBuyM6.4114,78594,77217,5782.8 K to 17.6 K (+529.36 %)
Sep 06 2016PRTAProthena Corp plcKinney Gene G.See RemarksOption ExerciseA52.2150,0002,610,50050,000
Feb 26 2016PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DOption ExerciseA34.6165,0002,249,65065,000
Dec 11 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DOption ExerciseM6.4130,000192,300170,000
Dec 11 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DSellS67.051,36091,1902,7934.2 K to 2.8 K (-32.75 %)
Dec 11 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DSellS66.3720,4391,356,5854,15324.6 K to 4.2 K (-83.11 %)
Dec 11 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DSellS65.468,201536,85124,59232.8 K to 24.6 K (-25.01 %)
Dec 11 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DBuyM6.4130,000192,30032,7932.8 K to 32.8 K (+1,074.11 %)
Mar 12 2015PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DOption ExerciseA27.8165,0001,807,65065,000
May 12 2014PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DBuyP19.542,50048,8502,793293 to 2.8 K (+853.24 %)
Feb 06 2014PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DOption ExerciseA29.8145,0001,341,45045,000
Jan 31 2013PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DOption ExerciseA6.41200,0001,282,000200,000
Jan 31 2013PRTAProthena Corp plcKinney Gene G.CSO & Head of R&DBuyJ0.00250293268 to 293 (+9.33 %)

Page:   1

Contact us | Follow us on Twitter